Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19
Supporting Files
Public Domain
-
10 2021
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We report in vivo selection of a severe acute respiratory syndrome coronavirus 2 spike mutation (Q493R) conferring simultaneous resistance to bamlanivimab and etesivimab. This mutation was isolated from a patient who had coronavirus disease and was treated with these drugs.
-
Subjects:
-
Source:Emerg Infect Dis. 27(10):2728-2731
-
Pubmed ID:34314668
-
Pubmed Central ID:PMC8462334
-
Document Type:
-
Volume:27
-
Issue:10
-
Collection(s):
-
Main Document Checksum:urn:sha256:5a019f37bc34f6e4f82ce812e828954ed8bf665d422aec9c3eabc28e50d83b8c
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases